FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885337411> ?p ?o ?g. }

• W2885337411 abstract "Insulin-like growth factor 1 (IGF1) plays an important role in breast cancer initiation and progression due to its regulation of cell proliferation, migration, and invasion. Our laboratory previously demonstrated that overexpression of constitutively activated IGF1 receptor (IGF1R) transformed human mammary epithelial cells and induced epithelial to mesenchymal transition. These characteristics make IGF1R an attractive therapeutic target, however, only subsets of patients have shown beneficial response to anti-IGF1R therapy in clinical trials, likely due to crosstalk with the insulin signaling pathway and lack of predictive biomarkers. To identify biomarkers of response to activated IGF1 and insulin signaling, we performed a proteomic screen in 21 breast cancer cell lines stimulated with IGF1 and insulin. We identified E-cadherin (CDH1), a major component of the adherens junction, as a repressor of IGF1 and insulin signaling. We further provide evidence that loss of E-cadherin hyperactivates the IGF1R pathway and increases sensitivity to IGF1R targeted therapy, thus highlighting the IGF1R pathway as a potential target in E-cadherin deficient breast cancer. Knockdown or antibody-mediated inhibition of E-cadherin increased IGF1-induced activation of IGF1R signaling and cell cycle progression. IGF1R and E-cadherin co-localized at points of cell-cell contact and a direct endogenous interaction using in situ proximity ligation assay indicated a physical regulation of E-cadherin on IGF1R signaling. Importantly, the E-cadherin gene (CDH1) is genetically lost in invasive lobular breast carcinoma (ILC), a subtype of breast cancer accounting for ~10-15% of total cases. We found increased expression of IGF1 ligand and levels of IGF1R phosphorylation in E-cadherin deficient estrogen receptor positive (ER+) ILC in TCGA compared to ER+ invasive ductal carcinomas (IDC). We demonstrated that IGF1R and PI3K/Akt pathway inhibitors were effective in inhibiting growth in ER+ ILC cell lines and synergized with endocrine therapy. Additionally, we showed efficacy of IGF1R inhibition in ILC xenografts cultured ex vivo. Our data supports the use of IGF1R pathway inhibition as a potential novel therapeutic strategy for the treatment of ILC." @default.
• W2885337411 created "2018-08-22" @default.
• W2885337411 creator A5013948896 @default.
• W2885337411 date "2018-03-26" @default.
• W2885337411 modified "2023-09-27" @default.
• W2885337411 title "Credentialing IGF1R pathway activation as a novel therapeutic target in E-cadherin deficient breast cancer" @default.
• W2885337411 cites W102166461 @default.
• W2885337411 cites W1523335221 @default.
• W2885337411 cites W1541739901 @default.
• W2885337411 cites W1871669466 @default.
• W2885337411 cites W1880346245 @default.
• W2885337411 cites W1908864745 @default.
• W2885337411 cites W1919599080 @default.
• W2885337411 cites W1963654222 @default.
• W2885337411 cites W1964442943 @default.
• W2885337411 cites W1967563608 @default.
• W2885337411 cites W1967899512 @default.
• W2885337411 cites W1970094205 @default.
• W2885337411 cites W1971439306 @default.
• W2885337411 cites W1973721983 @default.
• W2885337411 cites W1974842079 @default.
• W2885337411 cites W1979032468 @default.
• W2885337411 cites W1979485370 @default.
• W2885337411 cites W1982193563 @default.
• W2885337411 cites W1987172765 @default.
• W2885337411 cites W1990430867 @default.
• W2885337411 cites W1994212409 @default.
• W2885337411 cites W1995773596 @default.
• W2885337411 cites W1996148311 @default.
• W2885337411 cites W1997146974 @default.
• W2885337411 cites W1997595111 @default.
• W2885337411 cites W2001219721 @default.
• W2885337411 cites W2010399667 @default.
• W2885337411 cites W2015846334 @default.
• W2885337411 cites W2021611918 @default.
• W2885337411 cites W2023059800 @default.
• W2885337411 cites W2023657377 @default.
• W2885337411 cites W2026988350 @default.
• W2885337411 cites W2031915537 @default.
• W2885337411 cites W2032461554 @default.
• W2885337411 cites W2035447242 @default.
• W2885337411 cites W2036832250 @default.
• W2885337411 cites W2037308967 @default.
• W2885337411 cites W2037918682 @default.
• W2885337411 cites W2037977870 @default.
• W2885337411 cites W2038724799 @default.
• W2885337411 cites W2041780807 @default.
• W2885337411 cites W2042965279 @default.
• W2885337411 cites W2050566423 @default.
• W2885337411 cites W2055397252 @default.
• W2885337411 cites W2059977567 @default.
• W2885337411 cites W2065204747 @default.
• W2885337411 cites W2065774446 @default.
• W2885337411 cites W2066166280 @default.
• W2885337411 cites W2073305155 @default.
• W2885337411 cites W2074111028 @default.
• W2885337411 cites W2075467280 @default.
• W2885337411 cites W2077945404 @default.
• W2885337411 cites W2079547534 @default.
• W2885337411 cites W2079894826 @default.
• W2885337411 cites W2087767405 @default.
• W2885337411 cites W2088227103 @default.
• W2885337411 cites W2091473810 @default.
• W2885337411 cites W2094025115 @default.
• W2885337411 cites W2098294628 @default.
• W2885337411 cites W2098544382 @default.
• W2885337411 cites W2099129157 @default.
• W2885337411 cites W2102979193 @default.
• W2885337411 cites W2103273602 @default.
• W2885337411 cites W2106213925 @default.
• W2885337411 cites W2114505219 @default.
• W2885337411 cites W2114550587 @default.
• W2885337411 cites W2117350664 @default.
• W2885337411 cites W2117692326 @default.
• W2885337411 cites W2120070286 @default.
• W2885337411 cites W2124085083 @default.
• W2885337411 cites W2124358769 @default.
• W2885337411 cites W2124580184 @default.
• W2885337411 cites W2125618744 @default.
• W2885337411 cites W2125652724 @default.
• W2885337411 cites W2126041479 @default.
• W2885337411 cites W2126983941 @default.
• W2885337411 cites W2127342819 @default.
• W2885337411 cites W2131199058 @default.
• W2885337411 cites W2134539328 @default.
• W2885337411 cites W2135366183 @default.
• W2885337411 cites W2136179119 @default.
• W2885337411 cites W2137108912 @default.
• W2885337411 cites W2140593657 @default.
• W2885337411 cites W2141398932 @default.
• W2885337411 cites W2142739240 @default.
• W2885337411 cites W2143468862 @default.
• W2885337411 cites W2145742598 @default.
• W2885337411 cites W2149106642 @default.
• W2885337411 cites W2151420456 @default.
• W2885337411 cites W2151427219 @default.
• W2885337411 cites W2154466664 @default.
• W2885337411 cites W2157560932 @default.
• W2885337411 cites W2158430086 @default.
• W2885337411 cites W2161429749 @default.

• next